Quantessence Capital LLC Ocular Therapeutix, Inc Transaction History
Quantessence Capital LLC
- $340 Billion
- Q2 2025
A detailed history of Quantessence Capital LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Quantessence Capital LLC holds 11,467 shares of OCUL stock, worth $118,912. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,467Holding current value
$118,912% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding OCUL
# of Institutions
206Shares Held
136MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$148 Million4.71% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$132 Million23.46% of portfolio
-
Summer Road LLC West Palm Beach, FL12.6MShares$130 Million98.91% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$95 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $798M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...